What is Enzyme (MLN)?

Deep Dive

1. Purpose & Value Proposition

Enzyme aims to democratize asset management by moving it fully on-chain. Instead of relying on traditional, opaque fund structures, users can create non-custodial investment vaults as smart contracts. These vaults can hold diverse assets—from cryptocurrencies to real-world assets (RWAs)—and execute automated strategies, providing transparency, auditability, and global accessibility that legacy finance lacks (Enzyme).

2. Tokenomics & Governance

The MLN token is central to the protocol's mechanics and governance. Users must pay fees in MLN to access the network, calculated as 0.25% of the assets under management (AUM) linked to their vault. These paid tokens are automatically burned, creating a deflationary pressure. Simultaneously, up to 300,600 new MLN are minted annually to fund ecosystem development and grants, a process managed by the community-run Enzyme Council DAO (Tokenomics | Enzyme Documentation).

3. Ecosystem & Key Differentiators

Enzyme's infrastructure is modular, primarily through two offerings: Enzyme Blue, an all-in-one vault platform, and Enzyme Onyx, a wallet tokenization layer designed for institutions. Onyx enables "unrestricted asset management," allowing strategies to operate seamlessly across multiple blockchains and interact with any DeFi or centralized protocol. This focus on cross-chain interoperability and broad asset support sets it apart from simpler, single-chain competitors (Enzyme).

Conclusion

Enzyme is fundamentally a building block for the future of programmable finance, providing the secure, flexible infrastructure needed to create and manage tokenized funds. Will its focus on cross-chain execution and institutional-grade tooling drive the next wave of on-chain asset management?